![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/47 | (2006.01) |
G01N 33/68 | (2006.01) | ||
A61K 47/00 | (2006.01) | ||
A61P 3/00 | (2006.01) |
(11) | Patento numeris | 3354277 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 18161509.7 |
Europos patento paraiškos padavimo data | 2010-07-28 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-08-01 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-30 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
22919509 P | 2009-07-28 | US | |
30304410 P | 2010-02-10 | US | |
31751310 P | 2010-03-25 | US | |
33337210 P | 2010-05-11 | US | |
35933810 P | 2010-06-28 | US |
(72) |
DANIEL, Peter, F. , US
HEARTLEIN, Michael, W. , US
|
(73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
(54) | COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE |
COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE |